Calgary, Alberta (ots/PRNewswire) - "RVX-208 treated patients have significant lower MACE events in high risk CVD patients" TSX Exchange Symbol: RVX Resverlogix Corp. today announced new information arising from its ongoing analysis of data from both the SUSTAIN and ASSURE trials in atherosclerotic patients with high risk for recurrent events. This analysis, performed ...
Amsterdam (ots/PRNewswire) - Kilbee responsible for driving the portfolio globally including increased emphasis on digital and content CPhI, part of UBM Live, has announced the appointment of Chris Kilbee to the role of Group Director of the UBM Pharma Portfolio. Central to the role is responsibility for the strategic development and delivery of market leading event brands CPhI, ICSE, Inno-Pack and P-MEC, held in Europe, ...
Berlin (ots/PRNewswire) - Scientists in Europe are stepping up their efforts to bring Golden Rice into production, with its promise to alleviate one of the world's scourges, vitamin A deficiency. They have organized a nine-city European tour led by Dr. Patrick Moore, co-founder and former leader of Greenpeace. ...
Oudenaarde, Belgium (ots/PRNewswire) - Discover the machine behind the famous technology and its applications at the Europlasma booth 35266, in LVCC South Hall 4, January 7th till 10th Belgium based Europlasma, a world leader in low pressure plasma technology, is happy to present at CES 2014 its nanocoating systems ...
Hatfield, England (ots/PRNewswire) - Halaven(R) (eribulin) has received reimbursement approval in the Czech Republic as a highly innovative drug for patients with metastatic breast cancer, effective from the 1 January 2014. Eribulin is the first, single-agent chemotherapy to demonstrate a prolonged overall survival ...
Darmstadt, Germany (ots/PRNewswire) - - The European Commission's approval is based on the CHMP positive opinion - Label update comes in response to new biomarker data obtained from the OPUS study Merck Serono, the biopharmaceutical division of Merck, today announced that the European Commission has approved the ...
Takeda Pharmaceuticals International GmbH
Zurich Switzerland (ots) - Takeda Pharmaceuticals International GmbH ("Takeda") announced that the European decentralised procedure (DCP) was positively concluded for dexlansoprazole, a proton pump inhibitor (PPI) with a new dual- delayed release technology for the treatment of reflux disease. The regulatory process ...
Darmstadt, Germany (ots/PRNewswire) - - New agreement aims to translate CNIO research into new potential treatment options for cancer patients - License agreement encompasses two series of ATR inhibitors and a screening platform Merck Serono, the biopharmaceutical division of Merck, today announced that a license ...
Lyon, France (ots/PRNewswire) - France becomes second European country after the UK to provide nation-wide recommendation for zoster vaccination. The French National High Council for Public Health (HCSP) has recommended routine shingles vaccination for seniors from 65 to 74 years of age. In addition, during the ...
Amsterdam (ots/PRNewswire) - Growth in the World's second largest pharma region facilitated by innovation and loosened regulatory guidelines (Logo: http://photos.prnewswire.com/prnh/20130723/629764-a ) Leading events organiser, UBM Live announces that CPhI Japan [http://www.cphi.com/japan/home ] is returning for its twelfth year to Tokyo, from the 9th to the 11th ...
The International Osteoporosis Foundation (IOF)
Hongkong (ots) - A new report published today by the International Osteoporosis Foundation (IOF) warns of a dramatic rise in osteoporosis-related fractures in the Asia-Pacific region. With a projected 230% and 144% increase in those aged over 70 years and 50 years respectively, the number of hip fractures are expected to at least double by 2050. Therefore, although populations may live longer their musculoskeletal health ...
Darmstadt, Germany (ots/PRNewswire) - - Publication offers detailed results of START, including an exploratory analysis of the clinically meaningful survival prolongation with tecemotide maintenance therapy in a predefined subgroup of patients treated with concurrent chemoradiotherapy - As previously announced Merck ...
Lausanne, Switzerland And Mechelen, Belgium (ots/PRNewswire) - Today Biocartis and VIB announced their exclusive license agreement on a novel panel of microsatellite instability (MSI) biomarkers for several cancers, in particular colorectal cancer (CRC). This agreement will enable Biocartis to develop a unique and user-friendly assay, whereby MSI biomarkers can simply ...
Novo Nordisk, DAWN2TM, International Diabetes Federation, Steno Diabetes Center
Melbourne, Australia (ots/PRNewswire) - Results from the global Diabetes Attitudes, Wishes and Needs 2 study (DAWN2(TM)) presented today at a symposium during the World Diabetes Congress of the International Diabetes Federation (IDF), show that only 29% of people with diabetes report that their healthcare team ask ...
Brussels, Belgium (ots/PRNewswire) - Coinciding with the World Health Organization (WHO) European Ministerial Conference on the Prevention and Control of Non-Communicable Diseases in Turkmenistan, MEPs, patient and physician representatives are today meeting at the European Parliament to highlight that urgent ...
Amsterdam (ots/PRNewswire) - CPhI announces that CPhI and P-MEC India, run by leading events organiser UBM, is returning to the Bombay Convention and Exhibition Centre, Mumbai (India) from the 3rd to the 5th December 2013. The event will return with an increased scale, continuing its commitment to cater to all sectors of the pharma industry by co-locating with ICSE and ...
Hatfield, England (ots/PRNewswire) - Epilepsy treatment Fycompa(R)(perampanel) has today been approved for basic reimbursement in Finland. Perampanel is indicated as an adjunctive treatment for partial onset seizures, with or without secondarily generalised seizures, in people with epilepsy aged 12 years and older.[1] Perampanel is the first and only licensed ...
Chicago (ots/PRNewswire) - Developed in collaboration with leading clinicians, Philips' Vereos digital PET/CT system and IQon Spectral CT system[1] are designed to create a short path to the best care and help improve patient care At the 99th Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, Royal Philips today illustrated its technology leadership in medical imaging with the introduction of ...
CIOCC (Centro Intregral Oncológico Clara Campal)
Madrid (ots/PRNewswire) - - Pancreatic cancer is the fourth most common cause of cancer death in the EU and kills 95% of people affected - Experts from around the world are meeting in Madrid as new discoveries lead to new hope Experts in pancreatic cancer from around the world are meeting in Madrid today with new hope that real advances are within reach. Pancreatic ...
Montreal (ots/PRNewswire) - KLOX Technologies Inc. ("KLOX") is pleased to announce an exclusive supply, distribution and licensing agreement with Sandoz Canada for KLOX's innovative and proprietary LumiCleanse(TM) System (also known as Lumigel Cleanse) for the treatment of acne vulgaris, and for its skin ...
Darmstadt, Germany (ots/PRNewswire) - - CHMP recommendation comes in response to new biomarker data obtained from the OPUS study Merck Serono, the biopharmaceutical division of Merck, today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a ...
Vancouver, British Columbia (ots/PRNewswire) - NASDAQ: CRME TSX: COM Cardiome Pharma Corp. today announced that a publication titled, Pharmacological Cardioversion of Atrial Fibrillation with Vernakalant: Evidence in Support of the ESC Guidelines, was published in Europace, the official Journal of the European Heart ...
Düsseldorf, Germany (ots/PRNewswire) - New healthcare solutions developed with users and patients help improve the recovery process and treatment options for patients while supporting medical staff in their work Healthcare is constantly changing. The best way to deal with this change is for all parties in the sector to join forces. Philips is putting this principle into action under the banner "Transforming healthcare, ...
Laval, Quebec (ots/PRNewswire) - LumiCleanse[TM]is a clinically-proven treatment now available for all severities of acne vulgaris developed by KLOX in Canada, destined for the global acne market KLOX Technologies Inc. ("KLOX" or the "Company") is pleased to announce that it has received CE mark approval in Europe ...
Vancouver, British Columbia And Geneva (ots/PRNewswire) - - Company to host webcast and conference call today at 5:00 p.m. EST - NASDAQ: CRME TSX: COM Cardiome Pharma Corp. today announced that it has completed the acquisition of Correvio LLC ("Correvio"), a privately held pharmaceutical company headquartered in Geneva, Switzerland. Key benefits of the transaction include the following: - Accelerates Cardiome's launch of BRINAVESS(TM) (vernakalant IV) and its transformation ...
Darmstadt, Germany (ots/PRNewswire) - - New agreement marks the second collaboration between Merck and BeiGene Merck Serono, the biopharmaceutical division of Merck, today announced that a global licensing, co-development, and commercialization agreement for BeiGene-290 has been signed with BeiGene Co., Ltd., a ...
Lugano, Switzerland (ots) - Swiss Pharma Group Helsinn seals an alliance with Japanese company Chugai by granting exclusive distribution & licensing rights to commercialize its innovative phase III ghrelin receptor agonist in Germany, France, Benelux, UK and Ireland Swiss-based Helsinn group has granted Chugai ...
Shire plc & ViroPharma Incorporated
Dublin And Exton, Pennsylvania (ots/PRNewswire) - Earnings accretive, revenue growth-enhancing acquisition Shire plc and ViroPharma Incorporated today announce that their Boards of Directors have unanimously approved, and the companies have entered into, a merger agreement pursuant to which Shire will acquire all ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris, France (ots/PRNewswire) - Yervoy, an innovative immuno-oncology therapy that has demonstrated durable long-term survival in some patients,[1],[2] is now approved for use in previously-untreated patients Bristol-Myers Squibb today announced that the European Commission (EC) has approved YERVOY(R) (ipilimumab) ...
Hatfield, England (ots/PRNewswire) - Eisai announces today that it has expanded the marketing and supply agreement between its U.S. subsidiary Eisai Inc. and U.S-based Arena Pharmaceuticals Inc.'s Swiss subsidiary, Arena Pharmaceuticals GmbH, for the anti-obesity agent lorcaserin hydrochloride (lorcaserin) (U.S. ...